Parsons Capital Management’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Parsons Capital Management’s Portfolio EDVA Stock Details EDVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-208	Closed	-$5.35K	–	446
2024 Q4	$5.35K	Hold	208	–	–	﹤0.01%	441
2024 Q3	$8.38K	Hold	208	–	–	﹤0.01%	445
2024 Q2	$7.65K	Hold	208	–	–	﹤0.01%	439
2024 Q1	$15.3K	Hold	208	–	–	﹤0.01%	437
2023 Q4	$18.4K	Hold	208	–	–	﹤0.01%	429
2023 Q3	$19.6K	Hold	208	–	–	﹤0.01%	417
2023 Q2	$37.2K	Hold	208	–	–	﹤0.01%	425
2023 Q1	$54.5K	Hold	208	–	–	﹤0.01%	419
2022 Q4	$32K	Sell	208 -625	-75%	-$110K	﹤0.01%	415
2022 Q3	$183K	Hold	833	–	–	0.02%	403
2022 Q2	$398K	Hold	833	–	–	0.04%	313
2022 Q1	$378K	Sell	833 -62	-7%	-$31.6K	0.03%	336
2021 Q4	$167K	Hold	895	–	–	0.01%	428
2021 Q3	$287K	Buy	895 +625	+231%	+$282K	0.02%	376
2021 Q2	$157K	Buy	+270	New	+$148K	0.01%	417

Other funds holding EDVA

Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Parsons Capital Management's EDVA Position: Q1 2025 in Review

Parsons Capital Management sold out of Endovia Health Sciences, Inc. (EDVA) in Q1 2025, closing a stake of 208 shares — an estimated $5.35K sold.

Parsons Capital Management first reported a position in EDVA in Q2 2021 and held it in 15 quarters. The position peaked at $398K in Q2 2022. 11 funds tracked by Wall St. Rank hold EDVA as of Q1 2025.

Parsons Capital Management reported no remaining Endovia Health Sciences, Inc. position as of Q1 2025 after selling out during the quarter.
Parsons Capital Management sold 208 Endovia Health Sciences, Inc. shares in Q1 2025, an estimated $5.35K.
Parsons Capital Management first reported a position in Endovia Health Sciences, Inc. in Q2 2021 and held it in 15 quarters.
Parsons Capital Management's Endovia Health Sciences, Inc. position peaked at $398K in Q2 2022.
11 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q1 2025.

Based on Parsons Capital Management's 13F filing for Q1 2025, filed 15 Apr 2025.